280 likes | 481 Views
The Global Fund support for Tuberculosis control STOP TB Symposium 3 December 2009, Cancun Prof. Rifat Atun and Dr Mohamed Aziz. Global Fund support for the 3 diseases Global Fund support for Tuberculosis Round 9 for TB Results achieved The way forward. Countries with Global Fund Grants.
E N D
The Global Fund support for Tuberculosis controlSTOP TB Symposium 3 December 2009, CancunProf. Rifat Atun and Dr Mohamed Aziz
Global Fund support for the 3 diseases • Global Fund support for Tuberculosis • Round 9 for TB • Results achieved • The way forward
Countries with Global Fund Grants BG/281108/7
Regional DistributionRounds 1-8, (July 2009) Global Fund Grant Resources by Region 100% = US$ 15.9 billion Percentages of total funds approved by the Board, including Phase 2 & RCC OP/140709/2
Country Classification: by IncomelevelRounds 1-8, (July 2009) Global Fund Grant Resources by Income Level 100% =US$ 15.9 billion Percentages of total funds approved by the Board, including Phase 2 & RCC OP/140709/1
How are Grant Funds Used? Resources by Expenditure Component OP/140108/6
Global Fund support for the 3 diseases • Global Fund support for Tuberculosis • Round 9 for TB • Results achieved • The way forward
TB success rates (excluding HSS parts) Total Phase 1 funding approved: US$2.1 billion
Disease Components DistributionRounds 1-8, (July 2009) Global Fund Resources by Disease Component 100% = US$ 15.9 billion Percentages of total funds approved by the Board, including Phase 2 & RCC OP/140709/3
Global Fund Contribution to International Financing for Tuberculosis, 2008 Global Fund provided 57% of all international funding in 2008 Source: WHO Stop TB data, 2008 SE/260309/4
Tuberculosis CoverageAfter 8 Rounds of proposals 110 countries 184 components US$ 1.2 billion (2 years) US$ 3.1 billion (5 years) BG/281108/9
Global Fund support for the 3 diseases • Global Fund support for Tuberculosis • Round 9 for TB • Results achieved • The way forward
Round 9 and NSA Funding Recommendations • Phase 1 upper-ceiling amountsrecommended by the TRP for Round 9 and the First Learning Wave of National Strategy Applications (NSA) and AMFm: Round 9 US $ 2.2 billion NSA FLW US $ 434 million • Total Round 9 and NSA FLW recommended for funding: US $ 2.6 billion (Phase 1) and US $ 7.2 (Lifetime budget) (Board decision: 20th Board Meeting)
Round 9 and NSA Funding Recommendations • Round 9 overall success rate: 53% (85 of 159) (includes HSS s4B/5B) • NSA overall success rate: 71% (5 of 7) • 2 new single country beneficiaries recommended: Mexico andTurkmenistan
Round 9 - Number of proposals recommended and success rates Round 9 success rates (excluding HSS s4B/5B) Success rate 41% 59% 55% 50%
2 1 2 5 14 19 44 41% 11 50% 59% 55% 9 30 17 4 Category 1 Category 2 39 70 18 13 Category 2B Category 3 4 1 10 5 Category 4 HIV Tuberculosis Malaria Overall Round 9: Disease parts by TRP recommendation category and by disease Recommended for funding
NSA - Number of proposals recommended and success rates Success rate 33% 100% 100% 71%
Round 9 Success rate 52% 43% 50% 50% Round 8 Success rate 56% 50% 50% 53% Round 9: HSS cross-cutting requests
Global Fund support for the 3 diseases • Global Fund support for Tuberculosis • Round 9 for TB • Results achieved • The way forward
TB financing and cumulative new sputum positive cases detected and treated, by year
How Do Results Scale-up?June 2009 GP/110608/9
Average grant performance (results vs. grant targets) over time Performance: results vs. agreed-upon, time-bound targets
Achievement • To date, The GF approved treatment of 46 000 MDR cases • Yet less than half of the cases are treated through the GLC mechanism • With Round 9 grant life the total MDR supported with GF funding will reach 100 000 patients
Global Fund support for the 3 diseases • Global Fund support for Tuberculosis • Round 9 for TB • Results achieved • The way forward
Universal access to high quality TB control measures. • 2. Better targeted TB proposals which will increase success rate • 3. Increased emphasis on TB/HIV collaborative activities • Round 9 – not all TB proposals did include HIV activities and vice versa • Better communication from The Global Fund and Technical Organisations
Increased demonstration of cost-effectiveness of tuberculosis prevalence surveys in proposals as recommended by TRP in Round 9 • Repackaging TB messages to make it more positive and increase the focus on achievements and success stories. • Urgent need to scale up MDR treatment. • Inclusion of infection control measures. • 8. Better demonstration of HSS support in TB proposals.